Non-Hodgkin's Lymphoma

  • Medical Author:
    Jerry R. Balentine, DO, FACEP

    Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.

  • Medical Editor: Melissa Conrad Stöppler, MD
    Melissa Conrad Stöppler, MD

    Melissa Conrad Stöppler, MD

    Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.

View the Cancer Symptoms Women Ignore Slideshow

Quick GuideCancer 101 Pictures Slideshow: A Visual Guide to Understanding Cancer

Cancer 101 Pictures Slideshow: A Visual Guide to Understanding Cancer

What is the prognosis and survival rate for non-Hodgkin's lymphoma?

The prognosis of NHL can be good but is linked to the type of lymphoma, the extent of spread (staging), and response to therapy. Prognosis should be discussed with the patient's health-care provider.

Approximately 69,000 patients were diagnosed with non-Hodgkin's lymphoma in 2011, and about 19,000 patients died in 2013.

Five-year survival is a measure used to predict and gauge the severity of the cancer. Patients should discuss risk factors, staging, and classifications with their health-care team as none of these numbers should be applied to an individual patient without considering all the circumstances of the patient's illness.

The National Cancer Institute reports the following average five-year survival:

NHL Five-Year Survival
Stage at diagnosisStage distribution (%)Five-year relative survival (%)
Localized (confined to primary site)2881.6
Regional (spread to regional lymph nodes)1572.9
Distant (cancer has metastasized)4961.6
Unknown (unstaged)866.9

Where can people find more information about non-Hodgkin's lymphoma?

Leukemia & Lymphoma Society
1311 Mamaroneck Avenue, Suite 310
White Plains, NY 10605
Phone: 914-949-5213
Fax: 914-949-6691
http://www.lls.org/

REFERENCE:

United States. National Cancer Institute. "Non-Hodgkin Lymphoma." Sept. 2007.

Medically Reviewed by a Doctor on 4/1/2015
VIEW PATIENT COMMENTS
  • Non-Hodgkin's Lymphomas - Describe Your Experience

    Please describe your experience with non-Hodgkin's lymphoma.

    Post View 41 Comments
  • Non-Hodgkin's Lymphomas - Treatments

    What treatments were effective for your non-Hodgkin's lymphoma?

    Post View 12 Comments
  • Non-Hodgkin's Lymphoma - Symptoms

    What symptoms of non-Hodgkin's lymphoma did you experience when you were diagnosed?

    Post View 2 Comments
  • Non-Hodgkin's Lymphoma - Prognosis

    What's the prognosis of your non-Hodgkin's lymphoma?

    Post View 2 Comments

Health Solutions From Our Sponsors